Blind common anabolic steroid and aromatase inhibitors screening – raws
Blind HPLC screening of common anabolic steroids and aromatase inhibitors in raw API powders. The analysis identifies the target compound and determines its percentage content.
Blind HPLC identification of common anabolic steroids and selected aromatase inhibitors in oils, oral products, and raw API powders. The analysis reports the detected compound without quantification.
Blind HPLC screening of common anabolic steroids in oil-based samples. The analysis identifies and quantifies all detected target compounds, including mixtures.
Targeted HPLC analysis of DHT enanthate in oil-based samples and raw API powders. The test confirms compound identity and determines its content in mg/mL or percentage.
Targeted HPLC analysis of epistane in tablets, capsules, and raw API powders. The test confirms compound identity and determines its content in mg per unit or as a percentage.
Related content
Comparing loss-on-ignition, acid decarbonation and combustion elemental analysis for measuring organic carbon concentrations – recommendations for best practice
Comprehensive investigation of matrix effect evaluation approaches for reliable quantification in bioanalysis using UHPLC-MS/MS
Volatile compound fingerprinting for traditional sesame oil authentication using GC-MS with GC×GC-MS-assisted identification